Intas Pharmaceuticals Limited Oxaliplatin Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Oxaliplatin Export Records India — #10 Exporter, 32 Shipments, $790.8K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Oxaliplatin

India Pharmaceutical Trade Intelligence

$46.6M249 Suppliers123 CountriesHS 30049049

ExportsIndia → GERMANY21.5%India → RUSSIA13.9%

ImportsARGENTINA → India$44.5K ITALY → India$20.0K

#1 Supplier: FRESENIUS KABI #1 Buyer: FRESENIUS KABI

Intas Pharmaceuticals Limited — Oxaliplatin Exporter #10 | $790.8K Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Oxaliplatin Exporter Profile

Indian Pharmaceutical Exporter · #10 for Oxaliplatin · $790.8K export value · DGFT Verified

Intas Pharmaceuticals Limited is the #10 Indian exporter of Oxaliplatin with $790.8K in export value and 32 verified shipments. Intas Pharmaceuticals Limited holds a 1.7% market share in Oxaliplatin exports across 6 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Oxaliplatin Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Oxaliplatin export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Oxaliplatin?

Country	Value	Shipments	Share
BRAZIL	$459.3K	13	53.5%
NETHERLANDS	$128.9K	6	15.0%
PHILIPPINES	$72.5K	10	8.5%
FRANCE	$50.0K	1	5.8%
UNITED KINGDOM	$46.2K	1

Who Are the Top Buyers of Oxaliplatin from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
TO THE ORDER	BRAZIL	$162.3K	5
ACCORD FARMACUTICA LTDA.	BRAZIL	$146.7K	4
ACCORD FARMACUTICA LTDA	BRAZIL	$114.8K	3
XXCORXXHEAXXHCAXX B XX	FRANCE	$100.0K	2
ACCORD HEALTHCARE B V	NETHERLANDS	$76.6K	4
ACCORD HEALTHCARE LTD	ITALY	$46.7K	7
ASIA UNITED BANK CORPORATION	PHILIPPINES	$42.4K	4
XXCORXXHEAXXHCAXX INXX	UNITED STATES OF AMERICA	$36.5K	1
ACCORD FARMACUTICA LIMITEDA	BRAZIL	$35.6K	1
ACCORD HEALTHCARE C O QESTMED PTY	SOUTH AFRICA	$33.8K	1

Intas Pharmaceuticals Limited supplies Oxaliplatin to 20 buyers globally. The largest buyer is TO THE ORDER (BRAZIL), followed by ACCORD FARMACUTICA LTDA. (BRAZIL) and ACCORD FARMACUTICA LTDA (BRAZIL). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Oxaliplatin Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
PHARM DRUG&MED OXA OXALIPLATIN 5MG/ML,40ML 1V (ACC-BR) EACH ML CONTAINS: OXALIPLATIN PH.EUR 5 MG	$91.2K	3
PHARMACEUTICAL DRUGS AND MEDICINE - OXAOXALIPLATIN 5MG/ML,20ML 1V (ACC-BR) ASAPER INVOICE	$62.4K	2
OXALIPLATINLF5MG/ML,10MLACO-FRANCE	$50.2K	2
PHARMA DRUGS & MEDI OXA OXALIPLATIN 5MG/	$50.0K	1
PHARMA DRUGS AND MEDI OXA OXALIPLATIN 5MG/ML,20ML 1V ACC-BR AS PER INV	$50.0K	1
OXALIPLATINLF5MG/ML40MLACO-GERMANY	$50.0K	1
OXALIPLATIN(LF)5MG/ML 40ML(ACO-GERMANY	$50.0K	1
OXALIPLATINLF 5MG/ML,10MLACCORD-UK	$46.3K	2
OXALIPLATIN INJ 5MG/ML 10ML 1X1V	$36.5K	1
PHARMA DRUGS AND MEDICINE OXA OXALIPLATIN 5MG ML 20ML 1V ACC BR Each mL contains QTY 6720X1X1VIAL AS PER INV	$36.1K	1

Intas Pharmaceuticals Limited exports 34 distinct Oxaliplatin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARM DRUG&MED OXA OXALIPLATIN 5MG/ML,40ML 1V (ACC-BR) EACH with 3 shipments worth $91.2K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Intas Pharmaceuticals Limited Compare to Nearest Oxaliplatin Exporters?

Exporters ranked immediately above and below #10 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
5	GLAND PHARMA LIMITED	$1.0M	20	1	$50.0K
9	ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED	$850.0K	17	10	$50.0K
10	INTAS PHARMACEUTICALS LIMITED ★	$790.8K	32	6	$24.7K
11	NV REMEDIES PRIVATE LIMITED	$651.6K	16	4	$40.7K
6	MYLAN LABORATORIES LIMITED	$600.0K	12	1	$50.0K

Intas Pharmaceuticals Limited ranks #10 among 249 Indian Oxaliplatin exporters. Average shipment value of $24.7K compared to the market average of $130.9K. The closest competitors by value are GLAND PHARMA LIMITED and ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED.

Which Indian Ports Ship Oxaliplatin Exports?

Port	Shipments	% Share
DELHI AIR CARGO ACC (INDEL4)	535	17.4%
SAHAR AIR CARGO ACC (INBOM4)	453	14.7%
DELHI AIR	436	14.2%
SAHAR AIR	410	13.3%
CHAWAPAYAL ICD (INCPR6)	110	3.6%
Bombay Air	108	3.5%
NHAVA SHEVA SEA (INNSA1)	97	3.1%
CHAWAPAYAL ICD	95	3.1%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Oxaliplatin Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Oxaliplatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 47 individual customs records matching Intas Pharmaceuticals Limited exporting Oxaliplatin, covering 34 formulations to 10 countries via 20 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 123+ countries, 693+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Oxaliplatin

Oxaliplatin

Intas Pharmaceuticals Limited — Oxaliplatin Exporter Profile

Intas Pharmaceuticals Limited — Oxaliplatin Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Oxaliplatin?

Who Are the Top Buyers of Oxaliplatin from Intas Pharmaceuticals Limited?

What Is India's Total Oxaliplatin Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Oxaliplatin Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Oxaliplatin Exporters?

What Oxaliplatin Formulations Does Intas Pharmaceuticals Limited Export?

Regulatory Requirements: Exporting Oxaliplatin to Key Markets

Brazil — ANVISA

How Does Intas Pharmaceuticals Limited Compare to Nearest Oxaliplatin Exporters?

Which Indian Ports Ship Oxaliplatin Exports?

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Oxaliplatin Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Oxaliplatin Export Data from Intas Pharmaceuticals Limited

Oxaliplatin Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source